TMI-1
Product Specifications
CAS Number
287403-39-8
Target
Interleukin|||Caspase|||Apoptosis|||MMP|||TNF
Related Pathways
Proteases/Proteasome|||Apoptosis|||Immunology/Inflammation
Purity
0.9879
Bioactivity
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
Smiles
CC#CCOc1ccc(cc1)S(=O)(=O)N1CCSC(C)(C)[C@@H]1C(=O)NO
Molecular Formula
C17H22N2O5S2
Molecular Weight
398.5
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
218835-01 20 µL
BHLHE40 (Class E Basic Helix-loop-helix Protein 40, Basic Helix-loop-helix Family Member e40, DEC1, HLHB2, BHLHB2, STRA13, Stra14, SHARP-2) discontinued
Ask
View Details 218835-02 100 µL
BHLHE40 (Class E Basic Helix-loop-helix Protein 40, Basic Helix-loop-helix Family Member e40, DEC1, HLHB2, BHLHB2, STRA13, Stra14, SHARP-2) discontinued
Ask
View Details 
MBS6273730-01 0.2 mL
ANKRD61, CT (ANKRD61, Ankyrin repeat domain-containing protein 61) (AP)
Ask
View Details MBS6273730-02 5x 0.2 mL
ANKRD61, CT (ANKRD61, Ankyrin repeat domain-containing protein 61) (AP)
Ask
View Details